STYK1 and steatosis: Our data showed that Nok significantly improved the body weight and liver weight/index elevation, corrected glycolipid metabolism disorder, ameliorated glucose tolerance, decreased hepatic lipid accumulation and steatosis, and protected the liver function in HFD-induced MAFLD mice in vivo.